The Korean journal of helicobacter and upper gastrointestinal research (대한상부위장관⦁헬리코박터학회지)

Korean College of Helicobacter and upper Gastrointestinal Reseaarch (대한상부위장관ㆍ헬리코박터학회)
권호 표지
DOI QR코드

DOI QR Code

Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials

위축성 위염과 장상피화생의 유병률 변화 및 위험인자의 변화: 다기관 연구 비교

  • Hwang, Young-Jae (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Kim, Nayoung (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Kim, Sung Eun (Department of Internal Medicine, Kosin University College of Medicine) ;
  • Baik, Gwang Ho (Department of Internal Medicine, College of Medicine, Hallym University) ;
  • Lee, Ju Yup (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Park, Kyung Sik (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Joo, Young-Eun (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Myung, Dae-Seong (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Kim, Hyeon Ju (Department of Family Medicine, Jeju National University School of Medicine) ;
  • Song, Hyun Joo (Department of Internal Medicine, Jeju National University School of Medicine) ;
  • Kim, Heung Up (Department of Internal Medicine, Jeju National University School of Medicine) ;
  • Nam, Kwangwoo (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Shin, Jeong Eun (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Kim, Hyun Jin (Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine) ;
  • Kim, Gwang Ha (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Lee, Jongchan (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Lim, Seon Hee (Department of Internal Medicine, Seoul National University Healthcare System Gangnam Center and Healthcare Research Institute) ;
  • Seo, Geom Seog (Department of Internal Medicine, Wonkwang University School of Medicine) ;
  • Choi, Suck Chei (Department of Internal Medicine, Wonkwang University School of Medicine)
  • 황영재 (분당서울대학교병원 내과) ;
  • 김나영 (분당서울대학교병원 내과) ;
  • 김성은 (고신대학교 의과대학 내과학교실) ;
  • 백광호 (한림대학교 의과대학 내과학교실) ;
  • 이주엽 (계명대학교 의과대학 내과학교실) ;
  • 박경식 (계명대학교 의과대학 내과학교실) ;
  • 주영은 (전남대학교 의과대학 내과학교실) ;
  • 명대성 (전남대학교 의과대학 내과학교실) ;
  • 김현주 (제주대학교 의학전문대학원 가정의학교실) ;
  • 송현주 (제주대학교 의학전문대학원 내과학교실) ;
  • 김흥업 (제주대학교 의학전문대학원 내과학교실) ;
  • 남광우 (단국대학교 의과대학 내과학교실) ;
  • 신정은 (단국대학교 의과대학 내과학교실) ;
  • 김현진 (경상대학교 의과대학 내과학교실, 건강과학연구원) ;
  • 김광하 (부산대학교 의과대학 내과학교실) ;
  • 이종찬 (분당서울대학교병원 내과) ;
  • 임선희 (서울대학교병원 헬스케어시스템 강남센터 내과 및 헬스케어연구소) ;
  • 서검석 (원광대학교 의과대학 내과학교실) ;
  • 최석채 (원광대학교 의과대학 내과학교실)
  • Received : 2018.07.23
  • Accepted : 2018.09.06
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Background/Aims: The aim of this study was to analyze the trend of the prevalences of atrophic gastritis (AG) and intestinal metaplasia (IM) from 2011 to 2016~2017 in Korea. And, the risk factors of AG and IM were compared between 2011 and 2016~2017. Materials and Methods: A total of 4,023 subjects in 2011 and 2,506 subjects in 2016~2017 were enrolled. AG and IM were diagnosed on the basis of endoscopic findings. Multivariate analysis was performed for risk factors of AG and IM. Seventeen factors were analyzed. Results: The seroprevalence of Helicobacter pylori decreased from 2011 (59.8%; 2,407/4,023) to 2016~2017 (51.6%; 1,293/2,506; P<0.001). The prevalence of AG decreased from 2011 to 2016~2017 (P=0.018), but that of IM increased (P<0.001). The risk factors of AG in 2011 were male sex, old age, H. pylori immuoglobulin G (IgG) positivity, family history of gastric cancer (GC), and high-salt diet. For IM in 2011, the risk factors were male sex, old age, H. pylori IgG positivity, and family history of GC. Risk factors of AG in 2016~2017 were old age, H. pylori IgG positivity, and country of residence. For IM in 2016~2017, the risk factors were male sex, old age, family history of GC, high fasting glucose level (${\geq}126mg/dL$), H. pylori IgG positivity, and low income level. Conclusions: The difference in prevalence trends of AG and IM between 2016~2017 and 2011 could be the result of the different risk factors of AG and IM, such as decreased prevalence of H. pylori infection.

Keywords

Acknowledgement

Supported by : National Research Foundation of Korea (NRF)

References

  1. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 2018;50:303-316. https://doi.org/10.4143/crt.2018.143
  2. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-123. https://doi.org/10.4143/crt.2014.46.2.109
  3. Kim N, Park RY, Cho SI, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol 2008;42:448-454. https://doi.org/10.1097/MCG.0b013e318046eac3
  4. Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB. Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years. World J Surg Oncol 2014;12:217. https://doi.org/10.1186/1477-7819-12-217
  5. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008;9:279-287. https://doi.org/10.1016/S1470-2045(08)70072-X
  6. Lim HS, Chang YW, Lee BW, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Korean J Helicobacter Res Prac 2002;2:170-177.
  7. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044. https://doi.org/10.1002/ijc.21731
  8. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 2002;97:531-535. https://doi.org/10.1002/ijc.10111
  9. Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20 Suppl 1:S8-22. https://doi.org/10.1097/00000478-199600001-00003
  10. Kim JM. H. pylori-induced gastric mucosal apoptosis. Korean J Helicobacter Res Prac 2001;1:31-35.
  11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-6740.
  12. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994;54(7 Suppl):1941s-1943s.
  13. Lee H, Min BH, Lee JH, et al. Survival outcome associated with the screening interval for gastric cancer in Korea. Digestion 2011;84:142-148. https://doi.org/10.1159/000326857
  14. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002;16:1209-1216. https://doi.org/10.1046/j.1365-2036.2002.01300.x
  15. Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver 2015;9:5-17. https://doi.org/10.5009/gnl14118
  16. Kim N, Park YS, Cho SI, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008;13:245-255. https://doi.org/10.1111/j.1523-5378.2008.00604.x
  17. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 2017;112:212-239. https://doi.org/10.1038/ajg.2016.563
  18. Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. https://doi.org/10.1055/s-0031-1291491
  19. Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013;62:3-26. https://doi.org/10.4166/kjg.2013.62.1.3
  20. Joo YE, Park HK, Myung DS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver 2013;7:303-310. https://doi.org/10.5009/gnl.2013.7.3.303
  21. Seo GS, Jeon BJ, Chung JS, et al. The prevalence of erosive esophagitis is not significantly increased in a healthy Korean population-could it be explained?: a multi-center prospective study. J Neurogastroenterol Motil 2013;19:70-77. https://doi.org/10.5056/jnm.2013.19.1.70
  22. Kim SE, Kim N, Lee JY, et al. Prevalence and risk factors of functional dyspepsia in health check-up population: a nationwide multicenter prospective study. J Neurogastroenterol Motil 2018;24:603-613. https://doi.org/10.5056/jnm18068
  23. Nam KW, Shin JE, Kim SE, et al. Prevalence and risk factors for upper gastrointestinal diseases in health check-up subjects: a nationwide multicenter study in Korea. Scand J Gastroenterol 2018:1-7.
  24. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87-97. https://doi.org/10.1055/s-0028-1098086
  25. Liu Y, Uemura N, Xiao SD, Tytgat GN, Kate FJ. Agreement between endoscopic and histological gastric atrophy scores. J gastroenterol 2005;40:123-127. https://doi.org/10.1007/s00535-004-1511-x
  26. Kaminishi M, Yamaguchi H, Nomura S, et al. Endoscopic classification of chronic gastritis based on a pilot study by the research society for gastritis. Dig Endosc 2002;14:138-151. https://doi.org/10.1046/j.1443-1661.2002.00199.x
  27. Nagata N, Shimbo T, Akiyama J, et al. Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy. Gastroenterology Res 2011;4:203-209.
  28. Lee SY. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J Intern Med 2016;31:835-844. https://doi.org/10.3904/kjim.2016.166
  29. Lee SP, Lee SY, Kim JH, Sung IK, Park HS, Shim CS. Link between serum pepsinogen concentrations and upper gastrointestinal endoscopic findings. J Korean Med Sci 2017;32:796-802. https://doi.org/10.3346/jkms.2017.32.5.796
  30. Chung IS, Kim BW. Peptic ulcer diseases in Korea. Korean J Helicobacter Up Gastrointest Res 2012;12:19-22. https://doi.org/10.7704/kjhugr.2012.12.1.19
  31. Chang YW. Non-Helicobacter pylori, non-nonsteroidal anti-inflammatory drug peptic ulcer disease. Korean J Gastroenterol 2016;67:313-317. https://doi.org/10.4166/kjg.2016.67.6.313
  32. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-365. https://doi.org/10.1111/j.1440-1746.2008.05314.x
  33. Korean Helicobacter pylori Study Group. Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J Gastroenterol 1998;32:275-289.
  34. Kim N, Kim JJ, Choe YH, et al. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol 2009;54:269-278. https://doi.org/10.4166/kjg.2009.54.5.269
  35. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev 2015;20:25-40. https://doi.org/10.15430/JCP.2015.20.1.25
  36. Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014;20:5461-5473. https://doi.org/10.3748/wjg.v20.i18.5461
  37. Yoon H, Kim N, Shin CM, et al. Risk factors for metachronous gastric neoplasms in patients who underwent endoscopic resection of a gastric neoplasm. Gut Liver 2016;10:228-236. https://doi.org/10.5009/gnl14472
  38. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194. https://doi.org/10.1001/jama.291.2.187
  39. Hwang YJ, Kim N, Lee HS, et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication-a prospective study for up to 10 years. Aliment Pharmacol Ther 2018;47:380-390. https://doi.org/10.1111/apt.14424
  40. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterol 2000;119:7-14. https://doi.org/10.1053/gast.2000.8550
  41. Kim TH, Han SW. Atrophic gastritis: reversible after treatment? Korean J Helicobacter Up Gastrointest Res 2013;13:25-29. https://doi.org/10.7704/kjhugr.2013.13.1.25
  42. Salih BA, Abasiyanik MF, Saribasak H, Huten O, Sander E. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Dig Dis Sci 2005;50:1517-1522. https://doi.org/10.1007/s10620-005-2871-7
  43. Park HK, Kim N, Lee SW, et al. The distribution of endoscopic gastritis in 25,536 heath check-up subjects in Korea. Korean J Helicobacter Up Gastrointest Res 2012;12:237-243. https://doi.org/10.7704/kjhugr.2012.12.4.237
  44. Oh S, Kim N, Yoon H, et al. Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls. J Cancer Prev 2013;18:149-160. https://doi.org/10.15430/JCP.2013.18.2.149
  45. Kim HJ, Kim MK, Chang WK, Choi HS, Choi BY, Lee SS. Effect of nutrient intake and Helicobacter pylori infection on gastric cancer in Korea: a case-control study. Nut Cancer 2005;52:138-146. https://doi.org/10.1207/s15327914nc5202_4
  46. Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med 2016;31:1042-1053. https://doi.org/10.3904/kjim.2016.147
  47. Bures J, Kopacova M, Koupil I, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006;11:56-65. https://doi.org/10.1111/j.0083-8703.2006.00369.x
  48. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-1780. https://doi.org/10.1093/jnci/87.23.1777
  49. Kang KP, Lee HS, Kim N, et al. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009;24:140-148. https://doi.org/10.1111/j.1440-1746.2008.05546.x
  50. Marrollo M, Latella G, Melideo D, et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001;33:21-29. https://doi.org/10.1016/S1590-8658(01)80131-6
  51. Sekikawa A, Fukui H, Maruo T, Tsumura T, Okabe Y, Osaki Y. Diabetes mellitus increases the risk of early gastric cancer development. Eur J Cancer 2014;50:2065-2071. https://doi.org/10.1016/j.ejca.2014.05.020
  52. Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018;378:1085-1095. https://doi.org/10.1056/NEJMoa1708423
  53. Statistics Korea. Population structure by sex [Internet]. Daejeon: Statistics Korea, 2016 [updated 2016 Dec 12; cited 2016 Dec 12]. Available from: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1010.
  54. Redeen S, Petersson F, Jonsson KA, Borch K. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003;35:946-950. https://doi.org/10.1055/s-2003-43479
  55. Fung WP, Papadimitriou JM, Matz LR. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am J Gastroenterol 1979;71:269-279.

Cited by

  1. A Comparison of Accuracy between IMMULITE2000® and GENEDIA® for Helicobacter pylori Infection vol.20, pp.1, 2018, https://doi.org/10.7704/kjhugr.2019.0014